Randomized, double-blind study of flexibly-dosed intranasal esketamine plus oral antidepressant vs. active control in treatment-resistant depression

Vanina Popova; Ella Daly; Madhukar H. Trivedi; Kevin Cooper; R. Lane; Pilar Lim; Christine Mazzucco; David Hough; Michael E. Thase; Richard C. Shelton; Patricio Molero; Eduard Vieta; Malek Bajbouj; Husseini K. Manji; Wayne C. Drevets; Jaskaran Singh

doi:10.1016/j.euroneuro.2018.11.1005

Related publications

Article2018

S111. Randomized, Double-Blind Study of Flexibly-Dosed Intranasal Esketamine Plus Oral Antidepressant Vs. Active Control in Treatment-Resistant Depression

Vanina Popova, Ella Daly, Madhukar H. Trivedi, Kimberly Cooper, R. Lane, Pilar Lim, Christine Mazzucco, David Hough, Michael E. Thase, Richard C. Shelton, Patricio Molero, Eduard Vieta, Malek Bajbouj, Husseini K. Manji, Wayne C. Drevets, Jaskaran Singh

Article2025

Treatment-resistant depression and intranasal esketamine: Spanish consensus on theoretical aspects

Fernando Mora, Josep Antoni Ramos‐Quiroga, Enrique Baca‐García, José Manuel Crespo, Luís Gutiérrez-Rojas, Aránzazu Madrazo, Lucía Pérez-Costillas, Pilar A. Sáiz, Vicente Tordera, Eduard Vieta

Article2025

Treatment-resistant depression and intranasal esketamine: Spanish clinical consensus on practical aspects

Josep Antoni Ramos‐Quiroga, Fernando Mora, Silvia Arostegui, Narcı́s Cardoner, Jon-Iñaki Etxeandia-Pradera, Rocío Gómez-Juanes, Marcos Gómez‐Revuelta, José Manuel García Montes, Eduard Vieta

Article1995

Oral brivudin vs. intravenous acyclovir in the treatment of herpes zoster in immunocompromised patients: A randomized double‐blind trial

Peter Wutzler, De Clercq Erik, K Wutke, Inge Färber

Article2001

Oral liarozole in the treatment of palmoplantar pustular psoriasis: a randomized, double-blind, placebo-controlled study

M. Bhushan, A. David Burden, Kathleen McElhone, R. L. James, Frédéric Vanhoutte, Christopher Em Griffiths